Healthcare -
Biotechnology - NASDAQ - US
$ 8.71
-2.21 %
$ 327 M
Market Cap
4.73
P/E
TRDA - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities TRDA - Entrada Therapeutics, Inc.
103 M
LAST VALUE
1366.14%
2 YEAR CAGR
385.94%
5 YEAR CAGR
0.00%
10 YEAR CAGR